Karen Ringwald MD in Bluffton, Indiana

Home Indiana Bluffton

Karen Ringwald MD has Rheumatology as her primary medical specialty. Their primary office is: 303 S Main St in Bluffton, Indiana. There are 11 additional office locations for Karen Ringwald MD that can be viewed towards the end of their profile.

They're a part of the: Lutheran Medical Group Llc medical group which has around 253 members. You can call their office at 260-432-2297 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Medical College Of Ohio and graduated in 1999 (around 25 years of experience). They are listed as doing telehealth appointments.

Karen R Ringwald MD Office Phone and Directions

Karen Ringwald MD
Lutheran Medical Group Llc
303 S Main St
Bluffton, Indiana 46714
260-432-2297

Patient Ratings
Please rate your experience with Karen Ringwald MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 260-432-2297

Enter a starting address:

Healthcare Info for Karen Ringwald MD

Medical School: Medical College Of Ohio
Graduation Year: 1999
The Primary Medical Specialty for Karen Ringwald MD is listed as: Rheumatology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 25
PAC (PECOS ID)#: 7810963436
NPI #: 1922075084
NPI Created On: 03/07/2006
NPI Last Updated Listed as: 09/29/2020
Primary Taxonomy Code: 207RR0500X
License Number:
01055867A
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Celtic Insurance Company
Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Blood test, comprehensive group of blood chemicals
Manual urinalysis test with examination using microscope
Albumin (protein) level
Creatine kinase (cardiac enzyme) level
Blood creatinine level
Liver enzyme (sgot), level
Liver enzyme (sgpt), level
Complete blood cell count (red cells, white blood cell, platelets), automated test
Red blood cell sedimentation rate, to detect inflammation
Measurement c-reactive protein for detection of infection or inflammation
Rheumatoid factor analysis
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Physician telephone patient service, 11-20 minutes of medical discussion

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 797192159

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: KRYSTEXXA

Name of Drug #1: KRYSTEXXA

Open Associated Drug #1: 75987-080-10

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 797192165

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: KRYSTEXXA

Name of Drug #1: KRYSTEXXA

Open Associated Drug #1: 75987-080-10

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795838197

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: HUMIRA

Open Associated Drug #1: 0074-0554-02

Payments Total: $9

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795838201

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: HUMIRA

Open Associated Drug #1: 0074-0554-02

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795838205

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: RINVOQ

Open Associated Drug #1: 0074-2306-30

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795838209

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: RINVOQ

Open Associated Drug #1: 0074-2306-30

Payments Total: $5

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795838213

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: HUMIRA

Open Associated Drug #1: 0074-0554-02

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795838229

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: RINVOQ

Open Associated Drug #1: 0074-2306-30

Payments Total: $7

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795838217

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: HUMIRA

Open Associated Drug #1: 0074-0554-02

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795838221

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: RINVOQ

Open Associated Drug #1: 0074-2306-30